Welch & Forbes LLC Abb Vie Inc. Transaction History

Welch & Forbes LLC

$7.73 Billion
Q3 2024

A detailed history of Welch & Forbes LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Welch & Forbes LLC holds 364,569 shares of ABBV stock, worth $65.6 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares

364,569

Previous 370,852 1.69%

Holding current value

$65.6 Million

Previous $63.6 Million 13.19%

% of portfolio

0.93%

Previous 0.87%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$163.84 - $199.33 $1.03 Million - $1.25 Million	-6,283 Reduced 1.69%	364,569 $72 Million
Q2 2024 Aug 01, 2024	SELL	$154.79 - $180.76 $143,025 - $167,022	-924 Reduced 0.25%	370,852 $63.6 Million
Q1 2024 May 02, 2024	SELL	$159.82 - $182.1 $1.63 Million - $1.86 Million	-10,200 Reduced 2.67%	371,776 $67.7 Million
Q4 2023 Feb 06, 2024	SELL	$137.6 - $154.97 $1.8 Million - $2.03 Million	-13,090 Reduced 3.31%	381,976 $59.2 Million
Q3 2023 Nov 02, 2023	SELL	$133.59 - $154.65 $967,592 - $1.12 Million	-7,243 Reduced 1.8%	395,066 $58.9 Million
Q2 2023 Jul 28, 2023	SELL	$132.51 - $164.9 $661,489 - $823,180	-4,992 Reduced 1.23%	402,309 $54.2 Million
Q1 2023 Apr 14, 2023	SELL	$144.61 - $166.54 $1.18 Million - $1.36 Million	-8,163 Reduced 1.96%	407,301 $64.9 Million
Q4 2022 Feb 02, 2023	BUY	$138.31 - $165.87 $254,905 - $305,698	1,843 Added 0.45%	415,464 $67.2 Million
Q3 2022 Oct 28, 2022	SELL	$134.21 - $153.93 $187,759 - $215,348	-1,399 Reduced 0.34%	413,621 $55.5 Million
Q2 2022 Jul 22, 2022	SELL	$137.62 - $174.96 $1.05 Million - $1.34 Million	-7,638 Reduced 1.81%	415,020 $63.6 Million
Q1 2022 Apr 25, 2022	BUY	$131.98 - $163.75 $1.94 Million - $2.4 Million	14,679 Added 3.6%	422,658 $68.5 Million
Q4 2021 Jan 19, 2022	SELL	$107.43 - $135.93 $290,598 - $367,690	-2,705 Reduced 0.66%	407,979 $55.2 Million
Q3 2021 Oct 13, 2021	BUY	$106.4 - $120.78 $227,376 - $258,106	2,137 Added 0.52%	410,684 $44.3 Million
Q2 2021 Jul 22, 2021	BUY	$105.21 - $117.21 $267,022 - $297,478	2,538 Added 0.63%	408,547 $46 Million
Q1 2021 Apr 14, 2021	BUY	$102.3 - $112.62 $780,958 - $859,741	7,634 Added 1.92%	406,009 $43.9 Million
Q4 2020 Jan 20, 2021	SELL	$80.49 - $108.67 $379,751 - $512,705	-4,718 Reduced 1.17%	398,375 $42.7 Million
Q3 2020 Oct 23, 2020	BUY	$85.91 - $100.83 $304,980 - $357,946	3,550 Added 0.89%	403,093 $35.3 Million
Q2 2020 Jul 15, 2020	SELL	$73.37 - $98.18 $916,024 - $1.23 Million	-12,485 Reduced 3.03%	399,543 $39.2 Million
Q1 2020 Apr 17, 2020	SELL	$64.5 - $97.79 $442,083 - $670,252	-6,854 Reduced 1.64%	412,028 $31.4 Million
Q4 2019 Jan 17, 2020	SELL	$72.13 - $90.25 $258,441 - $323,365	-3,583 Reduced 0.85%	418,882 $37.1 Million
Q3 2019 Oct 11, 2019	SELL	$62.98 - $75.72 $1.02 Million - $1.23 Million	-16,183 Reduced 3.69%	422,465 $32 Million
Q2 2019 Jul 12, 2019	SELL	$65.7 - $83.98 $1.19 Million - $1.52 Million	-18,095 Reduced 3.96%	438,648 $31.9 Million
Q1 2019 Apr 29, 2019	SELL	$77.14 - $90.79 $1,697 - $1,997	-22 Reduced -0.0%	456,743 $36.8 Million
Q4 2018 Feb 05, 2019	SELL	$77.85 - $96.01 $369,320 - $455,471	-4,744 Reduced 1.03%	456,765 $42.1 Million
Q3 2018 Oct 17, 2018	BUY	$88.91 - $98.84 $115,494 - $128,393	1,299 Added 0.28%	461,509 $43.7 Million
Q2 2018 Jul 16, 2018	SELL	$89.78 - $106.23 $404,010 - $478,035	-4,500 Reduced 0.97%	460,210 $42.6 Million
Q1 2018 Apr 12, 2018	BUY	$92.01 - $123.21 $42.8 Million - $57.3 Million	464,710 New	464,710 $44 Million
Q4 2017 Jan 26, 2018	SELL	$89.56 - $98.21 $43.3 Million - $47.5 Million	-483,973 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $33.8 Million - $43.2 Million	483,973	483,973 $43 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch & Forbes LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch & Forbes LLC with notifications on news.

Account